Melvin Toh

Melvin Toh is Chief Technology Officer responsible for technology and clinical research and development activities of Polynoma. He is also the Vice President and Chief Scientific Officer of CK Life Sciences Int’l., (Holdings) Inc., Polynoma’s parent company. He holds Bachelor of Medicine and Bachelor of Surgery degrees from the National University of Singapore and a Master of Science degree in Epidemiology from the University of London. Dr. Toh has over 25 years of experience in clinical medicine and pharmaceutical research and development, and has held various management and scientific positions in Asia and the United States. Prior to his roles at Polynoma and CK Life Sciences Int’l., (Holdings) Inc., Dr. Toh was Director of Clinical Pharmacology in Oncology Development, directing a team of scientists working on the clinical development of new cancer drugs for a leading pharmaceutical firm in the United States.